SONN stock

Sonnet BioTherapeutics Holdings Inc [SONN] Revenue clocked in at $1.00 million, down -52.09% YTD: What’s Next?
Edison Baldwin
Sonnet BioTherapeutics Holdings Inc [NASDAQ: SONN] loss -59.35% or -1.84 points to close at $1.26 with a heavy trading volume ...





